HK:6872 Stock Latest News
Company AnnouncementsTenNor Extends Grand Life Science Termination Deadline5d ago6872
Company AnnouncementsTenNor Reports R&D Milestones for Two Core Drug Candidates6d ago6872
Company AnnouncementsTenNor Prioritizes Rifaquizinone for Prosthetic Joint Infection Market2w ago6872
Company AnnouncementsTenNor Therapeutics launches RMB50 million H-share buyback to signal confidence in valuation3w ago6872
Company AnnouncementsTenNor Advances First-in-Class PJI Antibiotic as Phase IIb Trial Reaches First-Patient Milestone3w ago6872Company AnnouncementsTenNor Therapeutics Calls 2026 Extraordinary Meeting to Revamp Incentives and Governance1M ago6872
Company AnnouncementsTenNor Therapeutics Launches 2026 H Share Incentive Plan and Adjusts Articles1M ago6872
Company AnnouncementsTenNor Therapeutics Narrows Loss and Advances Anti-Infective and CNS Pipeline2M ago6872
Company AnnouncementsTenNor Therapeutics Sets Board Meeting to Review Interim Results and Possible Dividend3M ago6872
Company AnnouncementsTenNor Therapeutics Wins Unanimous Backing at 2025 Shareholders’ Meeting4M ago6872
Company AnnouncementsTenNor Therapeutics Updates Articles After HKEX Listing and Withholds Final Dividend5M ago6872Company AnnouncementsTenNor Therapeutics Sets 2025 Annual Shareholders’ Meeting to Decide Governance and Profit Plans5M ago6872
Company AnnouncementsTenNor Therapeutics shifts corporate communications to electronic delivery5M ago6872
Company AnnouncementsTenNor Therapeutics moves corporate communications to electronic delivery for investors5M ago6872
Company AnnouncementsTenNor Therapeutics director resigns, remuneration committee vacancy to be filled5M ago6872
Company AnnouncementsTenNor Therapeutics Outlines Board and Committee Structure to Strengthen Governance5M ago6872
Company AnnouncementsTenNor Therapeutics Schedules Board Meeting to Consider Final Dividend5M ago6872

